ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,308
Screening encounters
2,525
Diagnostic referrals
491
Outstanding pathways
210

Screening pathway

  1. Screening2,525Encounters
  2. Positive finding847Documented findings
  3. Referral491Diagnostic referrals
  4. Follow-up550Diagnostic visits
  5. Outcome281Resolved pathways

Stage totals use different units. Pending pathways: 210. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2026-02-15, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

2308 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0558 · Expanded synthetic participant 0558Site B — Peri-Urban Access Programme
EXP-0562 · Expanded synthetic participant 0562Site C — Rural Outreach Programme
EXP-0566 · Expanded synthetic participant 0566Site E — Resource-Constrained Navigation Programme
EXP-0567 · Expanded synthetic participant 0567Site C — Rural Outreach Programme
EXP-0568 · Expanded synthetic participant 0568Site A — Urban Referral Hub
EXP-0569 · Expanded synthetic participant 0569Site D — Community Engagement Programme
EXP-0571 · Expanded synthetic participant 0571Site E — Resource-Constrained Navigation Programme
EXP-0575 · Expanded synthetic participant 0575Site C — Rural Outreach Programme
EXP-0577 · Expanded synthetic participant 0577Site D — Community Engagement Programme
EXP-0578 · Expanded synthetic participant 0578Site E — Resource-Constrained Navigation Programme
EXP-0580 · Expanded synthetic participant 0580Site D — Community Engagement Programme
EXP-0586 · Expanded synthetic participant 0586Site A — Urban Referral Hub
EXP-0587 · Expanded synthetic participant 0587Site A — Urban Referral Hub
EXP-0588 · Expanded synthetic participant 0588Site D — Community Engagement Programme
EXP-0589 · Expanded synthetic participant 0589Site E — Resource-Constrained Navigation Programme
EXP-0597 · Expanded synthetic participant 0597Site C — Rural Outreach Programme
EXP-0601 · Expanded synthetic participant 0601Site C — Rural Outreach Programme
EXP-0602 · Expanded synthetic participant 0602Site A — Urban Referral Hub
EXP-0604 · Expanded synthetic participant 0604Site B — Peri-Urban Access Programme
EXP-0608 · Expanded synthetic participant 0608Site E — Resource-Constrained Navigation Programme
EXP-0612 · Expanded synthetic participant 0612Site E — Resource-Constrained Navigation Programme
EXP-0614 · Expanded synthetic participant 0614Site A — Urban Referral Hub
EXP-0618 · Expanded synthetic participant 0618Site D — Community Engagement Programme
EXP-0620 · Expanded synthetic participant 0620Site C — Rural Outreach Programme
EXP-0626 · Expanded synthetic participant 0626Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1059
HPV DNA
1095
Cytology
371

Navigation activity

Barrier documented
415
Contact attempt
719
Navigation intervention
178
Diagnostic booking
608
Diagnostic visit
550

Documented barriers

Contact difficulty
132
Transport difficulty
136
Appointment coordination
147

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.